Here is an article based on the Business Wire French Language News release:
MaaT Pharma Provides Monthly Update on Voting Rights and Share Capital
Paris, France – July 7, 2025 – MaaT Pharma, a pioneer in the development of microbiome-based therapies, today released its monthly report detailing the total number of voting rights and shares that constitute its share capital. This regular disclosure is part of the company’s commitment to transparency and providing its stakeholders with up-to-date information regarding its corporate structure.
As of the reporting date, the company confirmed the number of outstanding shares and the corresponding total voting rights. This information is crucial for shareholders and potential investors as it reflects the current equity landscape of MaaT Pharma and the distribution of voting power within the company. Such updates are standard practice for publicly traded companies and are essential for maintaining investor confidence and facilitating informed decision-making.
MaaT Pharma continues to advance its innovative therapeutic programs, focusing on harnessing the power of the microbiome to address significant unmet medical needs, particularly in oncology and inflammatory diseases. The company’s ongoing research and development efforts, coupled with regular corporate updates, underscore its dedication to both scientific progress and transparent governance.
Investors and interested parties are encouraged to refer to the official regulatory filings and news releases issued by MaaT Pharma for the most precise and comprehensive details regarding their share capital and voting rights. This commitment to regular communication ensures that all stakeholders remain well-informed about the company’s evolution.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
Business Wire French Language News published ‘MaaT Pharma : Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social’ at 2025-07-07 16:00. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.